These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 19041066)

  • 1. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
    Ozdemir E; Akgedik K; Akdogan S; Kansu E
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
    Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
    Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of dimethylsulfoxide-related nausea and vomiting by prophylactic administration of ondansetron for patients receiving autologous cryopreserved peripheral blood stem cells.
    Eisenberg S; Wickline M; Linenberger M; Gooley T; Holmberg L
    Oncol Nurs Forum; 2013 May; 40(3):285-92. PubMed ID: 23615140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical side effects during peripheral blood progenitor cell infusion.
    Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
    Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components.
    Rowley S; MacLeod B; Heimfeld S; Holmberg L; Bensinger W
    Cytotherapy; 1999; 1(4):311-7. PubMed ID: 20440908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relevant low toxicities with rhG-CSF mobilized and cryopreserved autologous peripheral blood stem cell return infusions in children].
    Wang JW; Tang SQ; Lü SG; Ran CR; Yang G; Liu Y; Gao XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):404-7. PubMed ID: 17493357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
    Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
    Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases.
    Alessandrino P; Bernasconi P; Caldera D; Colombo A; Bonfichi M; Malcovati L; Klersy C; Martinelli G; Maiocchi M; Pagnucco G; Varettoni M; Perotti C; Bernasconi C
    Bone Marrow Transplant; 1999 Mar; 23(6):533-7. PubMed ID: 10217182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
    Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
    Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
    Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease.
    Mueller LP; Theurich S; Christopeit M; Grothe W; Muetherig A; Weber T; Guenther S; Behre G
    Eur J Haematol; 2007 Jun; 78(6):527-31. PubMed ID: 17509106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
    Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
    Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
    Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
    Hirabayashi N; Goto S; Morishima Y; Sao H; Matsuyama T; Kodera Y; Yamada H; Horibe K; Yano K; Kojima H; Ogura M; Tanimoto M; Morishita Y; Yazaki M; Utsumi M; Nagata K; Kato Y; Naoe T; Saito H
    Rinsho Ketsueki; 1998 Jan; 39(1):21-6. PubMed ID: 9492549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events of cryopreserved hematopoietic stem cell infusions in adults: a single-center observational study.
    Otrock ZK; Sempek DS; Carey S; Grossman BJ
    Transfusion; 2017 Jun; 57(6):1522-1526. PubMed ID: 28301051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion.
    Sánchez-Salinas A; Cabañas-Perianes V; Blanquer M; Majado MJ; Insausti CL; Monserrat J; Sánchez-Ibáñez MV; Menchón P; García-Hernández A; Gómez-Espuch J; Morales A; Moraleda JM
    Transfusion; 2012 Nov; 52(11):2382-6. PubMed ID: 22404870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical toxicity at the infusion of cryopreserved and thawed peripheral blood stem cell grafts in children].
    Okamoto Y; Takaue Y; Yasutomo K; Saito S; Hirao A; Matsunaga K; Abe T; Shimizu T; Sato J; Watanabe T
    Rinsho Ketsueki; 1992 Mar; 33(3):317-21. PubMed ID: 1578635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.